The Indian Express | 1 month ago | 12-08-2022 | 11:35 am
Dr. Atul Patel is a director and chief consultant for the Department of Infectious Diseases, Sterling Hospital. He is a visiting assistant professor at the Medicine Division of Infectious Diseases at the University of South Florida, Tampa, US. He has a special interest in HIV/TB co-infections. His group is researching on an effective programme to prevent mother-to-child transmission at the ID Clinic, AhmedabadThe past two years were largely uneventful with respect to swine flu and/or seasonal influenza cases and related mortality. We are again witnessing a surge this year. What is driving it?The term, swine flu, is used for the 2009 H1N1 strain, which was a recombinant of influenza viruses in birds, pigs and humans. The strain evolves every year, which is why these subsequent strains are termed under the broad category of seasonal influenza. The surge in seasonal influenza cases in a specific year depends on the general population’s immunity to the specific strain circulating in a specific year. We are seeing swine flu patients and seasonal influenza patients at present as both the viruses are in circulation. If we look at the epidemiology of seasonal influenza, it circulates in the community in tropical countries throughout the year with two big spikes — first in winter and the second in the monsoon. So this is the time when we expect an increase in the number of seasonal influenza cases. This is a major difference compared to temperate countries such as the US or Europe where only one surge is seen in the year that is winter.Right now we can say we are seeing an equal number of Covid-19 and seasonal influenza patients. In fact, the number of seasonal influenza cases is more compared to the last two years. That may be because we are not strictly wearing masks and sanitising hands, something that we did consistently through the two years during Covid-19. These are two important non-pharmaceutical interventions, which reduce the susceptibility to seasonal influenza as well as Covid-19. Furthermore, routine vaccination for seasonal influenza has gone down. It is not being highly recommended in high-risk groups by the government unlike pre Covid-19 years and has now taken a backseat following Covid-19. We can control the number of seasonal influenza patients in the community through vaccination and post-exposure prophylaxis with Oseltamivir (Tamiflu). We should promote an annual shot of the seasonal influenza vaccine in the media also.How does seasonal influenza impact an individual’s morbidity risk?Like Covid-19, those with co-morbidities are at a high risk of disease progression and complication when it comes to seasonal influenza. We are seeing that there is mortality in patients with significant co-morbidities. The sensitivities are almost the same as those for Covid-19 — haemato-oncological problems, malignancy, post-transplant cases, chronic obstructive lung disease, obesity, diabetes and so on.In terms of susceptibility to seasonal influenza, it is more or less equal across all age groups, except in paediatric patients and those aged above 65 years. These two groups are such that even without any co-morbid conditions, they are more prone to disease severity. For a majority of youngsters, most of whom are immuno-competent, seasonal influenza is a self-limiting disease. Symptoms include high grade fever, throat pain, headache, body pain, runny nose, which last for five to seven days or so. Then they report spontaneous and uneventful recovery. Taking fever-reducers such as Paracetamol work for healthy immuno-competent individuals but for paediatric and aged people, and those with comorbidities, we generally prescribe the antiviral drug Tamiflu, a very effective agent for influenza.With fever being the first symptom and the monsoon known for the resurgence of viral infections, seasonal influenza, vector-borne diseases, and now Covid-19, what should one look out for?With most viral infections, including dengue fever, the first episode is usually self-limiting in immuno-competent people. Such individuals report an uneventful recovery without much medical intervention. But those in high risk and co-morbid groups, should not ignore their fever, visit their doctor, get tested and secure a definite diagnosis.They should get a diagnostic evaluation done on the first day of the onset of symptoms rather than waiting for a few days as by then the disease can progress and complications may crop up. For healthy individuals who do not have many symptoms, except for fever and body pain, there is not much cause for worry. Their assessment and evaluation should be symptom-driven.With Covid-19 and seasonal influenza circulating in the population, how do we go about the diagnosis, given that most individuals just opt for a Covid-19 test? Surely a negative Covid-19 test doesn’t rule out an individual’s probability of seasonal influenza instead?We usually recommend the RT-PCR for both COVID-19 and seasonal influenza. In clinical practice, we have multiplex PCR. This assay includes a target panel of all the common viruses producing respiratory symptoms. So a single multiplex PCR can confirm whether it’s influenza A, influenza B, parainfluenza, COVID19, swine flu or other respiratory viruses. But it is very expensive, costing around Rs 11,500 or so, as it checks multiple pathogens. The results come within two-and-a-half hours and are highly reliable.How is a confirmed diagnosis of the type of seasonal influenza one is afflicted with significant for health management?Knowing the final and confirmed diagnosis is very important, as for the three viruses — influenza A, B and swine flu — Tamiflu is highly effective. Besides, most of these patients will respond to the antiviral drug within 48 hours of taking it. This is also one of the diagnostic traits that can be an indicator. So basically if someone improves markedly after taking Tamiflu, it can be said that he/she has been affected by one of the three viruses. That apart, a PCR test can tell you which kind it is because symptoms are more or less the same for seasonal influenza, swine flu or influenza B virus. From a clinical examination perspective, one can say that an individual has seasonal influenza but for the specific virus, only a PCR test can give a final and confirmed diagnosis.
The Covid-19 pandemic has increased the progression of complications arising from heart ailments, said Dr Sameer Dani, director, cardiology services, Apollo CVHF Heart Institute, Ahmedabad, adding that it can become a considerable risk factor if Covid-19 becomes endemic.Speaking a day before the World Heart Day on September 29, Dr Dani said, “Based on what we have observed, people who had pre-existing coronary artery diseases have more complications with Covid-19… more heart failures, more heart attacks and rapid progress of blockages.”Adding that even those who did not have pre-existing heart diseases stand higher chance to develop heart problems once they get Covid-19, Dani said, “We have seen three or four cases where a 10-20 per cent blockage before Covid-19, progressed to 90 per cent blockage in six to eight months after Covid. If it becomes endemic, then it will become important to take care of post-Covid precautions to prevent heart problems.”
New Delhi (India), September 27: NSE-listed, Libas Consumer Products Ltd is on fast track with several major diversifications whereby it has launched ‘KNG brand Organic Innerwear’ which are made of bamboo fiber, supposed to replace regular innerwear due to sustainable and non-allergic factor. KNG brand will be retailed exclusively on its website and few products of organic innerwear will be retailed through online multi-channel such as kng.ltd, Amazon, Flipkart, Myntra, Snapdeal, Meesho, Paytm Mall, Nykaa Fashion, Shopclues, etc.With the current size of the Indian inner wear or under wear market is Rs. 15,870 crores ($2.9 billion) which is expected to grow on a fast pace,KNG will be a clear winner.The company has just launched its first commercial store targetting middle class market in the hub of Bur dubai a commercial city in the middle East the company proposes to expand its foot print in the middle East with stores in Bahrain and Abu Dhabi also supplying uniform s to the 500 plus hotels opened in the after covid 2020 Libas is a lead supplier of accessories and uniform s to hotels like the AtlantisPost Covid, the wedding season in India is booming with stalled weddings for the last 2 years Riyaz Gangji Libas is all set to take advantage of all stalled weddings in Maharashtra and UP, Delhi it also retails through its website www.libasconsumerproductsltd.com and www.libasfashion.com, Amazon, Flipkart, Snapdeal, Meesho, Paytm Mall, Shopclues, whereby Libas Consumer Products ltd would gain substantially due to the wedding season .Last year ,Libas Consumer Products Ltd had announced a third bonus issue in 3 years and 2 dividends in recent years.Riyaz Gangji Libas has also signed an exclusive contract with Flex Wheeler, a bodybuilding legend, to retail in the USA and other parts of the world.With these positive developments, profitability and revenues may rise substantially.Big Renowned HNI investors are holding shares in Libas, giving a boost to its credibility.The company has proposed to raise investment to open stores across India through franchise models.The company has three production facilities in Mumbai, Delhi, Dubai .In light of the on-going COVID-19 pandemic and due to the temporary slowdown faced in the current business segment, the company is diversifying and derisking its business by venturing into Online Segment of manufacturing and selling of goods .The company’s mother brand ‘Libas’ is considered as one of the most reputed ethnic wear brands in India.The other brands of the company include Libas Riyaz Gangji, Libas Reshma Gangji, Gangji Jewels and KNG, Reshma Riyaz gangji Libas.Libas is the preferred label amongst stars in the IndianFilm Industry.Many Celebrities who have endorsed the company by wearing outfits designed Libas including, Amitabh Bachchan, Salman Khan, Zarine Khan, ZeenatAmaan, Anil Kapoor, Jacqueline Fernandes, Sonu Sood, etc. Music Maestro A.R. Rehman’s first international video makeover had clothes designed by Libas.The global ethnic wear market size was valued at USD 77.6 billion in 2020 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028. There has been a high demand for ethnic wear of various countries across the world because of globalisation, movement of culture & tradition in conjunction with individuals visiting and staying in numerous countries.Expansion into the international markets would expand cultural activities and wants desired by the company to serve various markets in the global world.
AHMEDABAD: The city on Monday recorded 22 new Covid cases and the death of one patient, taking the total number of active cases to 244. Gujarat registered 85 cases and active cases reduced to 981. After 111 days, the daily case count dropped below 100, and after 102 days, the active case count fell below 1,000. Five out of 33 districts recorded zero active cases.
The Gujarat government provided appointment letters and apprenticeship contract letters to 1.49 lakh youths at employment appointment letter distribution programmes held in 33 districts and seven municipalities in the state on Monday.“Providing employment opportunities to 1.49 lakh youth is historic,” said Chief Minister Bhupendra Patel as handed over the letters to 17 youths in Ahmedabad.Attributing the development in Gujarat to the strong foundation laid by Prime Minister Narendra Modi, the CM said that today Gujarat has become the growth engine of the country.“During the Covid pandemic, even major countries got tired. At that time, PM Modi gave the call of Atmanirbhar Bharat… through free vaccination, the PM got us out of Covid and made sure no one slept hungry during that time by providing free ration,” CM said.Describing the comprehensive development of the state, the CM said that Gujarat has become identical with strong development in every sector under the direction of PM Modi.“Two decades ago, the state was producing 99 MW of renewable energy that has reached 16,588 MW today and 8,750 MW power generation has reached 40,138 MW,” he said adding that 26 per cent of Narmada’s water that was taken for use has now reached 94.86 per cent.Two decades ago there were 2.74 lakh MSME industries in the state which has now increased to 8.66 lakh, he added. With the support of the state government and private institutions, 2.17 lakh students are being trained in 125 courses in the 600 ITIs in the state to create a skilled workforce, he added.Under the Mukhyamantri Apprentice Scheme, more than one lakh youth were trained in four years, he said.“More than three lakh employment have been provided to youths through rozgar melas. In the past five months, nearly 900 rozgar melas were organised. More than two lakh jobs were given through Anubandham portal that links employers and employees… and 13,000 vacancies are still available on the portal,” said principal secretary Labour, Skill Development and Employment Department Anju Sharma.
Post Covid pandemic and after a gap of two and half years, the Pune team of surgeons from Galaxy Care hospital flew to Gujarat over the weekend to carry out a record back to back uterine transplants in two women in their 20s. “Prior to the pandemic, nine uterine transplants – all in Maharashtra -were performed.Now with the Gujarat government giving permission for uterine transplant, our team decided to carry out the procedure for the women on Sunday (Sept 25),” Dr Shailesh Puntambekar, medical director at Galaxy care hospital told The Indian Express. The next state to invite the team is West Bengal where the team is already planning their next surgery.On Monday morning the entire 11 member team returned to Pune and according to Dr Puntambekar both uterine transplant procedures were completed in a span of nine hours. According to Dr Milind Telang, chief gynaecologist with Galaxy Care hospital, the two women who underwent uterine transplants are stable.“The first patient was a 28 year old woman who had a small uterus and was infertile. Her mother was 49 and as per the transplant norms were evaluated. The second woman had an absent uterus and suffered from a condition called Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome and was married for three years. She was evaluated and her mother also agreed to donate her uterus. Both patients and their families were counselled,” Dr Telang said. The incidence of MRKH syndrome is one in 5000 girls that are born.“In our Indian scenario it would approximate to nearly 1.25 lakh girls who are born with this condition,” Dr Telang said. Both cases were of absolute uterine factor infertility. The entire procedure was completed in less than 12 hours. “Starting at 9 am we finished both operations by 7.45 pm,” Dr Telang said. Both donor and recipients are stable with no blood transfusion.Both women were earlier registered with the hospital in Pune for the transplant. Pune’s Galaxy Care hospital had conducted India’s first two successful uterine transplants in May 2017 with the third one in January 2018 being completed by the team in six hours.The womb transplants were performed through laparoscopic surgery that made the surgeries painless and helped in faster recovery. After nine uterine transplants the Covid pandemic brought about a temporary stop to the procedures.While the institute awaits a formal inspection and renewal of its license as a uterine transplant centre the Gujarat government in the meantime had invited Dr Puntambekar and his qualified team members to perform the transplant in Ahmedabad. The permission from the Gujarat government was like a bonus for the families of the transplant recipients as they could stay in their home state and undergo the procedure, Dr Puntambekar said.The transplants were performed at the Institute of Kidney Diseases and Research Centre at the Ahmedabad civil hospital campus.The state authorization committee, transplantation of human organ act, government of Gujarat had granted registration of uterus transplant centre to the institute and in a letter issued recently had stated that during the first year the uterus transplantation has to be done by Dr Shailesh Puntambekar and his qualified team members.Dr Vasanthi Ramesh, Director of National Organ and Tissue Transplant Organisation (NOTTO) when contacted told The Indian Express that the registry is in the process of being updated. “Uterine transplantation is not a life saving procedure. However one can live without a uterus and hence it can be a life enhancing or life giving procedure,” Dr Ramesh said.